|
|
|
|
|
|
|
|
ANNUAL “ADVANCING
IMMUNOMODULATION” MEETING
HILTON ROME AIRPORT HOTEL, ROME, ITALY
|
|
|
|
|
|
This information is intended only for healthcare professionals in Europe.
|
|
|
|
Chair/moderator: Prof Attilio Olivieri
|
|
|
|
09:30 – 09:45
|
Arrival and registration
|
|
|
|
09:45 – 10:00
|
Introduction
Prof. A. Olivieri, AOU – University Hospital Ancona, Ancona, Italy
|
|
|
|
10.00 – 10.30
|
The pathophysiology of Graft vs Host Disease (GvHD): Main alterations in the immune cell subsets
Prof. M. Edinger, University Hospital Regensburg, Regensburg, Germany
|
|
|
|
10.30 – 11.00
|
The importance of immunomodulation in acute Graft vs Host Disease (aGvHD)
Prof. F. Dazzi, King’s College London, UK
|
|
|
|
11.15 – 11.30
|
Coffee break
|
|
|
|
11.30 – 12.00
|
The therapeutic approaches in acute Graft vs Host Disease (aGvHD)
Prof. F. Ayuk, University Hospital Hamburg-Eppendorf, Hamburg, Germany
|
|
|
|
12.00 – 12.30
|
Extracorporeal Photopheresis (ECP): an immunomodulatory therapy in the treatment of acute Graft vs Host Disease (aGvHD)
Prof. A. Bacigalupo, Gemelli University Hospital, Catholic University of the Sacred Heart, Rome, Italy
|
|
|
|
14.00 – 14.30
|
The current and potential use of Extracorporeal Photopheresis (ECP) in chronic Graft vs Host Disease (cGvHD)
Prof. D. Wolff, University Hospital Regensburg, Regensburg, Germany
|
|
|
|
14.30 – 15.00
|
The Italian scenario: the GITMO (Gruppo Italiano per il Trapianto di Midollo Osseo) survey on chronic Graft versus Host Disease (cGvHD)
Prof. A. Olivieri, AOU – University Hospital Ancona, Ancona, Italy
|
|
|
|
15.15 – 15.40
|
The cost-effectiveness of an integrated system to perform Extracorporeal Photopheresis (ECP): From Global to Italian perspectives
Dr. O. A. Mesa, Mallinckrodt Pharmaceuticals
|
|
|
|
15.40 – 16.00
|
Wrap up and closure
Prof. A. Olivieri, AOU – University Hospital Ancona, Ancona, Italy
|
|
|
|
All speakers are subject to contract.
This is a commercial programme run by Therakos (UK) Ltd, a Mallinckrodt Company
|
|
|
|
|
|
|
| |
